HAROLD G. MORSE, M.D.; WILLIAM J. EPPERSON, M.D.; JOSEPH M. KOVAZ, M.D.; JOHN D. WARE, M.D.; STUART M. BARNES, M.D.; JAMES E. BLECKLEY, M.D.; WILLIAM W. WALKER, M.D.; FREDERIC G. JONES, M.D.
To the editor: We read with interest the recent review and recommendations of Smith and Kennedy (1) for thrombolysis in acute myocardial infarction. Coronary thrombolysis has been shown in several multicenter randomized trials to reduce mortality when done early in the course of acute myocardial infarction (2-4). Most published series in the United States have been done in academic medical centers in conjunction with acute angiography. According to 1986 American Hospital Association statistics (5), only about 15% of hospitals in the United States have cardiac catheterization laboratories; therefore, most infarctions are treated initially in hospitals with no access to acute
MORSE HG, EPPERSON WJ, KOVAZ JM, WARE JD, BARNES SM, BLECKLEY JE, et al. Community Hospital Experience with Intravenous Streptokinase. Ann Intern Med. ;107:255. doi: 10.7326/0003-4819-107-2-255
Download citation file:
Published: Ann Intern Med. 1987;107(2):255.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use